Compare TALK & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TALK | UROY |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 656.0M | 601.8M |
| IPO Year | N/A | N/A |
| Metric | TALK | UROY |
|---|---|---|
| Price | $3.90 | $4.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $4.88 | $4.50 |
| AVG Volume (30 Days) | 1.6M | ★ 3.8M |
| Earning Date | 02-19-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.03 | 0.00 |
| Revenue | ★ $214,593,000.00 | $27,076,881.00 |
| Revenue This Year | $23.86 | $275.63 |
| Revenue Next Year | $22.25 | N/A |
| P/E Ratio | ★ $159.51 | $1,784.86 |
| Revenue Growth | ★ 18.37 | N/A |
| 52 Week Low | $2.22 | $1.43 |
| 52 Week High | $4.36 | $5.52 |
| Indicator | TALK | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 45.43 |
| Support Level | $3.84 | $4.39 |
| Resistance Level | $4.24 | $4.82 |
| Average True Range (ATR) | 0.18 | 0.43 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 37.38 | 11.78 |
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.